It is a trading private limited company based in Chennai, Tamil Nadu, India, established in 2010.
2010 | Chennai, Tamil Nadu, India | Struck OffSulwen Pharmaceuticals Private Limited, a struck off private limited company, was established on 12 July 2010 in Chennai, Tamil Nadu, India. Engaging in wholesale within the trading sector, it holds CIN: U51909TN2010PTC076563. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Kannan Umamaheshwari (Director), Thanikachalam (Director), Arunkumar Radhakrishnan (Director). Past directors included Gopalakrishnan Sundararaj, Nandhakumar Jegadeesan, Umamaheshwari Kannan. Its latest AGM occurred on 27 September 2013, with the balance sheet filed on 31 March 2013. It is based at No.202, Ground Floor, Mugappair Eari Scheme Mugappair East, Chennai, Tamil Nadu, 600037.
U51909TN2010PTC076563
076563
12 July 2010
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Struck Off
Explore comprehensive insights into Sulwen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannan Umamaheshwari | Director | 12 Jul 2010 | Current |
| Thanikachalam | Director | 12 Jul 2010 | Current |
| Arunkumar Radhakrishnan | Director | 12 Jul 2010 | Current |
| Kavitha | Managing Director | 12 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Aug 2011 | Past |
| Pramod Abcsdd | Director | 20 Sep 2011 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sulwen Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sulwen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sulwen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sulwen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sulwen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sulwen Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2013 as per latest MCA records. was recorded as a recent event.
Progress on Sulwen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Chennai. was documented.
The activity Kannan Umamaheshwari was appointed as a Director was appointed as a Director on 12 Jul 2010 & has been associated with this company since 15 years 4 months . was completed.
Progress on Thanikachalam was appointed as a Director was appointed as a Director on 12 Jul 2010 & has been associated with this company since 15 years 4 months . was documented.
Progress on Arunkumar Radhakrishnan was appointed as a Director was appointed as a Director on 12 Jul 2010 & has been associated with this company since 15 years 4 months . was documented.
Progress on Kavitha was appointed as a Managing Director was appointed as a Managing Director on 12 Jul 2010 & has been associated with this company since 15 years 4 months . was documented.
The CIN of Sulwen Pharmaceuticals Private Limited is U51909TN2010PTC076563.
Sulwen Pharmaceuticals Private Limited is headquartered at No.202, Ground Floor, Mugappair Eari Scheme Mugappair East, Chennai, Tamil Nadu, 600037.
Sulwen Pharmaceuticals Private Limited was incorporated on 12 July 2010.
The current directors of Sulwen Pharmaceuticals Private Limited are
The primary industry of Sulwen Pharmaceuticals Private Limited is Trading.
Sulwen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sulwen Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX